AI-focused precision medicine company raises $200M

Tempus, a Chicago-based precision medicine company that uses machine learning, genomic sequencing and other AI innovations, has raised $200 million in a series F funding round, the company announced. The financing brings the company’s valuation up to $3.1 billion, and it has raised $520 million since it was founded in September 2015.

Tempus claims to bring AI to healthcare by building the world’s largest library of molecular and clinical data, with an accessible and usable platform. The company’s work helps physicians and researchers make real-time, data-driven decisions for patients to benefit from treatments. The platform uses machine learning, next-generation sequencing and AI-assisted image recognition to discover...